Rationally derived drug combinations with the novel Mcl-1 inhibitor EU-5346 in breast cancer.

Sonia ValletFengjuan FanStefano MalvestitiMartin PecherstorferMartin SattlerAndreas SchneeweissHenning Schulze-BergkamenJoseph T OpfermanMichael H CardoneDirk JägerKlaus Podar

Published in: Breast cancer research and treatment (2018)

These data strongly support the further clinical development of EU-5346 to improve BC patient survival.

Keyphrases

case report
electronic health record
big data
emergency department
young adults